MedTrace Logo

Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

NCT04725695 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2025-02-06

No results posted yet for this study

Summary

In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper GI endoscopy

Conditions

  • Anesthetics, Local
  • Esophagogastroduodenoscopy

Interventions

DRUG

Viscous Lidocaine

The patients will be randomized to either viscous lidocaine or placebo

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Erling Oma, MD, PhD · Digestive Disease Center, Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-29
Primary Completion
2023-12-15
Completion
2024-10-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725695 on ClinicalTrials.gov